A Phase 2, Randomized, Double-Blind, Placebo and Active-Controlled Trial of LY2951742 in Patients With Mild to Moderate Osteoarthritis Pain of the Knee

Trial Profile

A Phase 2, Randomized, Double-Blind, Placebo and Active-Controlled Trial of LY2951742 in Patients With Mild to Moderate Osteoarthritis Pain of the Knee

Discontinued
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Galcanezumab (Primary) ; Celecoxib
  • Indications Osteoarthritis; Pain
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 17 Jun 2017 Interim results presented at the 18th Annual Congress of the European League Against Rheumatism.
    • 11 Jun 2017 Results (n=266) assessing the effects of galcanezumab on blood pressure, presented at the 59th Annual Scientific Meeting of the American Headache Society.
    • 29 Jun 2015 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top